UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (48880) 48880
Newspaper Article (1359) 1359
Book Chapter (882) 882
Newsletter (188) 188
Book / eBook (70) 70
Magazine Article (58) 58
Transcript (43) 43
Trade Publication Article (26) 26
Conference Proceeding (9) 9
Dissertation (8) 8
Government Document (5) 5
Book Review (4) 4
Web Resource (4) 4
Reference (3) 3
Publication (2) 2
Report (2) 2
Streaming Video (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (42078) 42078
life sciences & biomedicine (36976) 36976
humans (31848) 31848
oncology (20185) 20185
animals (18815) 18815
tumors (17808) 17808
female (16413) 16413
cancer (15379) 15379
male (12487) 12487
mice (12221) 12221
cell line, tumor (11874) 11874
metastasis (8024) 8024
chemotherapy (7843) 7843
research (7805) 7805
care and treatment (7696) 7696
middle aged (7598) 7598
cancer therapies (7219) 7219
apoptosis (7006) 7006
patients (6499) 6499
health aspects (6406) 6406
analysis (6331) 6331
aged (6020) 6020
adult (5956) 5956
proteins (5954) 5954
gene expression (5918) 5918
breast cancer (5509) 5509
research article (5272) 5272
medicine (5259) 5259
science & technology - other topics (5029) 5029
cell biology (4876) 4876
xenograft model antitumor assays (4727) 4727
immunotherapy (4698) 4698
tumor burden - drug effects (4697) 4697
mutation (4554) 4554
multidisciplinary sciences (4520) 4520
studies (4475) 4475
kinases (4433) 4433
medical prognosis (4390) 4390
prognosis (4356) 4356
treatment outcome (4325) 4325
mice, nude (4212) 4212
neoplasms. tumors. oncology. including cancer and carcinogens (4115) 4115
immunology (4052) 4052
medical research (4031) 4031
inflammation (4021) 4021
development and progression (3986) 3986
cytokines (3983) 3983
metastases (3914) 3914
genetic aspects (3908) 3908
antineoplastic agents - pharmacology (3891) 3891
cell proliferation - drug effects (3802) 3802
clinical trials (3767) 3767
review (3724) 3724
signal transduction (3650) 3650
science (3593) 3593
apoptosis - drug effects (3575) 3575
biochemistry & molecular biology (3552) 3552
biomarkers (3379) 3379
tumor necrosis factor-tnf (3354) 3354
medicine & public health (3316) 3316
pharmacology & pharmacy (3313) 3313
tumor burden (3292) 3292
surgery (3285) 3285
cell proliferation (3266) 3266
disease models, animal (3247) 3247
antineoplastic agents - therapeutic use (3219) 3219
medicine, research & experimental (3202) 3202
research & experimental medicine (3202) 3202
risk factors (3132) 3132
lung cancer (3103) 3103
drug therapy (3083) 3083
mice, inbred balb c (2910) 2910
hematology (2717) 2717
rodents (2648) 2648
cell cycle (2646) 2646
cytotoxicity (2597) 2597
colorectal cancer (2570) 2570
lymphocytes (2570) 2570
biology (2476) 2476
deoxyribonucleic acid--dna (2422) 2422
physiological aspects (2402) 2402
melanoma (2399) 2399
antigens (2398) 2398
aged, 80 and over (2391) 2391
gene expression regulation, neoplastic (2368) 2368
stem cells (2350) 2350
immune system (2316) 2316
cancer research (2276) 2276
diagnosis (2258) 2258
time factors (2258) 2258
usage (2247) 2247
angiogenesis (2177) 2177
immunohistochemistry (2155) 2155
mortality (2155) 2155
cell survival - drug effects (2146) 2146
mice, inbred c57bl (2134) 2134
signal transduction - drug effects (2129) 2129
cell growth (2105) 2105
breast neoplasms - pathology (2085) 2085
dose-response relationship, drug (2064) 2064
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (9) 9
Gerstein Science - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Online Resources - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (51443) 51443
Chinese (161) 161
Japanese (59) 59
German (50) 50
French (28) 28
Portuguese (26) 26
Norwegian (23) 23
Spanish (15) 15
Russian (12) 12
Italian (8) 8
Turkish (8) 8
Dutch (4) 4
Ukrainian (4) 4
Arabic (3) 3
Danish (3) 3
Croatian (2) 2
Bulgarian (1) 1
Polish (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell stem cell, ISSN 1934-5909, 07/2016, Volume 19, Issue 1, pp. 23 - 37
Adipose tissue (AT) has previously been identified as an extra-medullary reservoir for normal hematopoietic stem cells (HSCs) and may promote tumor... 
Adaptation, Physiological | Tumor Burden/drug effects | Fatty Acids/metabolism | Humans | Leukemia, Myeloid, Acute/drug therapy | Mice, Inbred C57BL | Cytoprotection/drug effects | Drug Resistance, Neoplasm/drug effects | Lipolysis/drug effects | Neoplastic Stem Cells/drug effects | Oxidation-Reduction/drug effects | Mice, Knockout | Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy | Antineoplastic Agents/pharmacology | Animals | Blast Crisis/drug therapy | Energy Metabolism/drug effects | Adipose Tissue/pathology | Gonads/pathology | CD36 Antigens/metabolism | Inflammation/pathology | Cell & Tissue Engineering | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Inflammation - pathology | Blast Crisis - drug therapy | Lipolysis - drug effects | Neoplastic Stem Cells - drug effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Gonads - pathology | Antineoplastic Agents - therapeutic use | CD36 Antigens - metabolism | Neoplastic Stem Cells - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Cytoprotection - drug effects | Oxidation-Reduction - drug effects | Leukemia, Myeloid, Acute - drug therapy | Neoplastic Stem Cells - pathology | Antineoplastic Agents - pharmacology | Fatty Acids - metabolism | Blast Crisis - pathology | Leukemia, Myeloid, Acute - pathology | Adipose Tissue - pathology | Tumor Burden - drug effects | Energy Metabolism - drug effects | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2018, Volume 378, Issue 22, pp. 2093 - 2104
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 8/2011, Volume 68, Issue 2, pp. 445 - 455
The natural flavonoid fisetin was recently identified as a lead compound that stabilizes endothelial cell microtubules. In this study, we investigated the... 
Fisetin | Lewis lung carcinoma | Angiogenesis | Antitumour activity | Cyclophosphamide | Medicine & Public Health | Cancer Research | Oncology | Cytotoxicity | EA·hy 926 endothelial cells | Pharmacology/Toxicology | Flavonoid | EA•hy 926 endothelial cells | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | NIH 3T3 Cells | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Tubulin Modulators - pharmacology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - pharmacology | Flavonoids - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Flavonoids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Flavonoids - administration & dosage | Tubulin Modulators - administration & dosage | Female | Flavonoids - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Angiogenesis Inhibitors - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Cell Line | Cell Survival - drug effects | Tubulin Modulators - adverse effects | Mice, Inbred C57BL | Angiogenesis Inhibitors - pharmacology | Tubulin Modulators - therapeutic use | Carcinoma, Lewis Lung - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Cell Movement - drug effects | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endothelial Cells - cytology | Neovascularization, Pathologic - drug therapy | Cyclophosphamide - pharmacology | Carcinoma, Lewis Lung - pathology | Cell Proliferation - drug effects | Mice | Antineoplastic Agents, Alkylating - adverse effects | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Endothelial Cells - drug effects | Antimitotic agents | Flavonoids | Flavones | Lung cancer | Bioflavonoids | Accountants | Drug therapy, Combination | Universities and colleges | Antineoplastic agents | Endothelium | Tumors | Index Medicus | cytology | Antineoplastic Agents, Phytogenic | pathology | Cell Proliferation | Endothelial Cells | Tubulin Modulators | Neovascularization, Pathologic | fisetin | administration & dosage | pharmacology | flavonoid | Carcinoma, Lewis Lung | Antineoplastic Agents, Alkylating | cytotoxicity | drug therapy | Cell Survival | angiogenesis | Antineoplastic Combined Chemotherapy Protocols | drug effects | Tumor Burden | Angiogenesis Inhibitors | EA.hy 926 | Cell Cycle | antitumour activity | adverse effects | therapeutic use | Cell Movement
Journal Article
Molecular neurobiology, ISSN 0893-7648, 11/2016, Volume 53, Issue 9, pp. 6251 - 6269
Selegiline is a monoamine oxidase-B (MAO-B) inhibitor with anti-Parkinsonian effects, but it is metabolized to amphetamines... 
Selegiline | p53 gene knockout mice | Oxidative stress | Neurosciences | Neurobiology | N -Methyl,  N -propynyl-2-phenylethylamine | Behavioral safety | Pro-apoptosis | Cell Biology | Neurology | Mitochondria | Biomedicine | Parkinson’s disease | N-Methyl, N-propynyl-2-phenylethylamine | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Electron Transport Complex I | Apoptosis - drug effects | Dopaminergic Neurons - pathology | Selegiline - pharmacology | Caspase 3 - metabolism | Membrane Potential, Mitochondrial - drug effects | Tumor Suppressor Protein p53 - genetics | Behavior, Animal | Neostriatum - drug effects | Dopaminergic Neurons - metabolism | Protein Binding - drug effects | Dopaminergic Neurons - drug effects | Neostriatum - metabolism | Superoxide Dismutase - metabolism | Locomotion - drug effects | Selegiline - chemistry | Phenethylamines - pharmacology | Oxidation-Reduction | Uncoupling Protein 2 - metabolism | Cytochromes c - metabolism | Mice, Inbred C57BL | Tumor Suppressor Protein p53 - metabolism | Phenethylamines - chemistry | Mitochondria - metabolism | Mitochondria - drug effects | Sulfonamides - pharmacology | Animals | Conditioning (Psychology) | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Cytosol - metabolism | Selegiline - analogs & derivatives | Oxidative Stress - drug effects | bcl-X Protein - metabolism | Monoamine Oxidase - metabolism | Cytochrome c | Safety and security measures | Monoamine oxidase | Genes | Superoxide | Tumor proteins | Nervous system agents | Apoptosis | Parkinsons disease | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2019, Volume 37, Issue 4, pp. 318 - 327
Journal Article
Molecular imaging and biology, ISSN 1536-1632, 2/2014, Volume 16, Issue 1, pp. 53 - 62
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2018, Volume 29, Issue 11, pp. 2214 - 2222
Journal Article